07Jun 2023
Prevalence, characteristics and cardiovascular and non‐cardiovascular outcomes in patients with heart failure with supra‐normal ejection fraction: Insight from the JROADHF study

Prevalence, characteristics and cardiovascular and non‐cardiovascular outcomes in patients with heart failure with supra‐normal ejection fraction: Insight from the JROADHF study

The study aimed to compare the characteristics and prognosis of patients with heart failure (HF) with supra-normal ejection fraction (HFsnEF) to those with HF with normal ejection fraction (HFnEF). The research involved analyzing data from a nationwide registry of hospitalized HF patients in Japan. Among the patients, 16.8% had HFsnEF, while 28.3% had HFnEF. Patients with HFsnEF were older, more likely to be women, had lower natriuretic peptide values, and smaller left ventricles compared to those with HFnEF. The primary endpoint, a composite of cardiovascular death or HF readmission, did not differ significantly between the two groups. However, HFsnEF showed a higher risk for certain outcomes in women and patients with renal dysfunction. In conclusion, HFsnEF is a common and distinct phenotype with different characteristics and prognoses compared to HFnEF.

  • #cardiology

Like

Save

Share